FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and represents a pharmaceutical composition for treating Parkinson's disease, containing a pharmaceutically acceptable carrier and a combination of flat doses of controlled release pramipexole and controlled release rasagiline; the above combination of flat doses contains pramipexole in an amount of 0.06 mg to less than 1.5 mg and rasagiline in an amount of 0.05 mg to less than 1.0 mg.
EFFECT: invention provides the synergetic action of rasagiline and pramipexole in treating Parkinson's disease.
3 cl, 11 dwg, 3 ex, 1 tbl
